TIAM1 and colorectal carcinoma: In the nucleus, TIAM1 inhibits the interaction between TAZ/YAP and TEAD, reducing EMT-related gene expression (AMOTL2, ANKRD1, AXL, CTGF, and CYR61), Wnt pathway activation facilitates TIAM1 nuclear translocation, thereby reducing CRC invasion and migration (89).